Location History:
- Wiesbaden-Auringen, DE (1980)
- Auringen, DE (1985 - 1986)
- Wiesbaden, DE (1978 - 1998)
Company Filing History:
Years Active: 1978-1998
Title: Heinz-Joachim Hinze: Innovator in Pharmaceutical Chemistry
Introduction
Heinz-Joachim Hinze is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that enhance cerebral blood flow. With a total of 8 patents to his name, Hinze's work has had a considerable impact on medical science.
Latest Patents
Hinze's latest patents include the development of 7-methoxymethyl-3-methyl-1-(5-oxohexyl)xanthine. This invention involves a Rhodotorula rubra strain that effectively reduces pentoxifylline to 100%, yielding the S-alcohol. Additionally, other oxoalkylxanthine derivatives can also be converted into the corresponding S-alcohol. The microbiologically obtained S-(+)-enantiomers can then be stereoselectively transformed into the respective R-(-)-enantiomers. The resulting S-alcohols and R-alcohols, obtained through enantioselective inversion of configuration, contribute to an increase in cerebral blood flow.
Career Highlights
Heinz-Joachim Hinze is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on innovative research and development, leading to his numerous patents and advancements in drug formulation.
Collaborations
Hinze has collaborated with notable colleagues such as Harald Furrer and Alfons Soder. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Heinz-Joachim Hinze's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the industry. His work continues to influence advancements in medical science and improve therapeutic options for patients.